IMPORTANCE OF DEFICIENCY RESPONSE IN PHARMACEUTICAL ENVIRONMENT FOR DRUG APPROVAL

Journal Title: International Journal of Drug Regulatory Affairs - Year 2014, Vol 2, Issue 4

Abstract

This illustrates examples of series deficiencies, that’s how really company faces problem due to deficiency. It’s to convey the message if drug product manufacturer can visualize earlier all aspect of risks and manifest proactively, then there is always least chance to have the said deficiency received. However, even then if company also gets deficiency, company could have equipped with earlier data. So, what they need to do is to focus properly for addressing agency’s query by utilizing proper scientific and technical writing skills. How lack of visualization creates problem, how review cycle prolonged and how by dint of this issue approval got delayed has been clearly discussed in this case study. The reason of so many rounds of questions and review cycles become longer and finally approval got delayed is from the beginning itself agency was not satisfied or convinced with the justification given by said Company.

Authors and Affiliations

Swagat Tripathy, Murthy P. N

Keywords

Related Articles

PHARMACY PROFESSION IN GUJARAT: AN OVERVIEW

Pharmacy is the health profession that links the health science with chemical science and it is charged with ensuring the safe and effective use of pharmaceutical drugs. Gujarat has been one of the pioneer States in Indi...

ORGANOGELS AS A POTENTIAL TOPICAL DRUG DELIVERY SYSTEM

Semisolid preparations for external application to skin have gained much demand, since it is easily absorbed through the skin layers. Many novel topical dosage forms have been discovered, among which organogels appears t...

Covering Global Pharmaceutical Regulations in a Quality System

This article describes how to address compliance with a wide range of applicable regulations within a company’s quality system. The focus is on the way regulatory intelligence can be obtained and subsequently be interpre...

CLINICAL TRIAL IN INDIA: RISE AND FALL

Fight with the disease is the ever evolving frontier for human beings. Discovery of new drugs and devices through clinical research are the armory to help in the fight with the affliction of mankind. Clinical trials, tes...

Drug approval process in India and Europe

Every time a new drug is developed it requires a great amount of research work in manufacturing, Pre- clinical Science, Controls, Chemistry & Clinical trials. Regulatory agencies have Drug Reviewers who has the responsib...

Download PDF file
  • EP ID EP343063
  • DOI -
  • Views 104
  • Downloads 0

How To Cite

Swagat Tripathy, Murthy P. N (2014). IMPORTANCE OF DEFICIENCY RESPONSE IN PHARMACEUTICAL ENVIRONMENT FOR DRUG APPROVAL. International Journal of Drug Regulatory Affairs, 2(4), 14-18. https://europub.co.uk/articles/-A-343063